VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)

VTEU：为下呼吸道感染 (LRTI) 治疗提供信息的非劣效性试验

• 批准号: 9361330
• 负责人: Mark Joseph Mulligan
• 金额: $ 6.78万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-06-15 至 2017-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9361330
• 关键词: Antimicrobial Resistance; Bacterial Drug Resistance; Clinical Research; Communicable Diseases; Conduct Clinical Trials; Contracts; Diagnostic; Individual; Lower Respiratory Tract Infection; Population; Resources; Therapeutic Human Experimentation; Translational Research; combat; design; named group; pathogen; programs

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同组成，为临床试验的设计和进行提供现成的资源，以评估有前途的产品来对抗传染病。 一般而言，产品将在正常健康人群中进行评价;然而，也可用于特殊人群。